X-Biotix Therapeutics, Inc. (X-Biotix), a biotechnology company focused on the discovery and development of first-in-class antibiotic compounds targeting multi-drug-resistant Gram-negative pathogens, announced today a change in its strategy, which will include suspension of its current antibacterial research efforts.
Link:
businesswire.com/news/home/20210426005029/en/X-Biotix-Therapeutics-Announces-Change-in-Corporate-Strategy
No comments:
Post a Comment